Topical Delivery of microRNA-125b by Framework Nucleic Acids for Psoriasis Treatment

References

• Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2(1):16082. doi:10.1038/nrdp.2016.82
   PubMed Web of Science ®Google Scholar
• Xiuli Y, Honglin W. miRNAs Flowing Up and Down: the Concerto of Psoriasis. Front Med. 2021;8. doi:10.3389/fmed.2021.646796
   Web of Science ®Google Scholar
• Jiang X, Huang S, Cai W, et al. Glutamine-Based Metabolism Normalization and Oxidative Stress Alleviation by Self-Assembled Bilirubin/V9302 Nanoparticles for Psoriasis Treatment. Adv Healthcare Mater. 2023;12(13):2203397. doi:10.1002/adhm.202203397
   Web of Science ®Google Scholar
• Jiang X, Yao Q, Xia X, et al. Self-assembled nanoparticles with bilirubin/JPH203 alleviate imiquimod-induced psoriasis by reducing oxidative stress and suppressing Th17 expansion. Chem Eng J. 2022;431:133956. doi:10.1016/j.cej.2021.133956
   Web of Science ®Google Scholar
• Shen H, Tian Y, Yao X, Liu W, Zhang Y, Yang Z. MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5) / FZD8 through β-catenin signaling in psoriasis. Die Pharmazie. 2017;72(8):461–467. doi:10.1691/ph.2017.7018
   PubMed Web of Science ®Google Scholar
• Xu N, Brodin P, Wei T, et al. MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2. J Invest Dermatol. 2011;131(7):1521–1529. doi:10.1038/jid.2011.55
   PubMed Web of Science ®Google Scholar
• Lerman G, Avivi C, Mardoukh C, et al. MiRNA Expression in Psoriatic Skin: reciprocal Regulation of hsa-miR-99a and IGF-1R. PLoS One. 2011;6(6):e20916. doi:10.1371/journal.pone.0020916
   PubMed Web of Science ®Google Scholar
• Wei T, Folkersen L, Biskup E, et al. Ubiquitin‐specific peptidase 2 as a potential link between microRNA‐125b and psoriasis. Br J Dermatol. 2017;176(3):723–731. doi:10.1111/bjd.14916
   PubMed Web of Science ®Google Scholar
• Jia H-Y, Zhang K, W-J L, G-W X, Zhang J-F, Tang Z-L. LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8. BMC Mol Cell Biol. 2019;20(1):46. doi:10.1186/s12860-019-0229-9
   PubMed Web of Science ®Google Scholar
• Srivastava A, Nikamo P, Lohcharoenkal W, et al. MicroRNA-146a suppresses IL-17–mediated skin inflammation and is genetically associated with psoriasis. J Allergy Clin Immunol. 2017;139(2):550–561. doi:10.1016/j.jaci.2016.07.025
   PubMed Web of Science ®Google Scholar
• Deng Y, Chang C, Lu Q. The Inflammatory Response in Psoriasis: a Comprehensive Review. Clin Rev Allergy Immunol. 2016;50(3):377–389. doi:10.1007/s12016-016-8535-x
   PubMed Web of Science ®Google Scholar
• Feng H, Wu R, Zhang S, et al. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice. J Dermatol. 2020;47(2):147–154. doi:10.1111/1346-8138.15149
   PubMed Web of Science ®Google Scholar
• Pradyuth S, Rapalli VK, Gorantla S, Waghule T, Dubey SK, Singhvi G. Insightful exploring of microRNAs in psoriasis and its targeted topical delivery. Dermatologic Therapy. 2020;33(6):e14221. doi:10.1111/dth.14221
   PubMedGoogle Scholar
• Wu R, Zeng J, Yuan J, et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest. 2018;128(6):2551–2568. doi:10.1172/JCI97426
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen Z, Wang C, Huang P, Luo M, Zhou R. STAT3/SH3PXD2A-AS1/miR-125b/STAT3 positive feedback loop affects psoriasis pathogenesis via regulating human keratinocyte proliferation. Cytokine. 2021;144:155535. doi:10.1016/j.cyto.2021.155535
   PubMed Web of Science ®Google Scholar
• Zheng Y, Cai B, Li X, Li D, Yin G. MiR-125b-5p and miR-181b-5p inhibit keratinocyte proliferation in skin by targeting Akt3. Eur J Pharmacol. 2019;862:172659. doi:10.1016/j.ejphar.2019.172659
   PubMed Web of Science ®Google Scholar
• Pan M, Huang Y, Zhu X, Lin X, Luo D. miR‑125b‑mediated regulation of cell proliferation through the Jagged‑1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis. Mol Med Rep. 2019;19(6):5227–5236. doi:10.3892/mmr.2019.10187
   PubMed Web of Science ®Google Scholar
• Chen R, Zhai -Y-Y, Sun L, et al. Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment. Asian J Pharm Sci. 2022;17(2):268–283. doi:10.1016/j.ajps.2022.02.003
   PubMed Web of Science ®Google Scholar
• Yan K, Zhang F, Ren J, Huang Q, Yawalkar N, Han L. MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis. J Transl Med. 2023;21(1):678. doi:10.1186/s12967-023-04427-6
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille -J-J, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8):5082–5089.
   PubMed Web of Science ®Google Scholar
• Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020;19(10):673–694. doi:10.1038/s41573-020-0075-7
   PubMed Web of Science ®Google Scholar
• Lee SWL, Paoletti C, Campisi M, et al. MicroRNA delivery through nanoparticles. J Control Release. 2019;313:80–95. doi:10.1016/j.jconrel.2019.10.007
   PubMed Web of Science ®Google Scholar
• Ding H, Li J, Chen N, et al. DNA Nanostructure-Programmed Like-Charge Attraction at the Cell-Membrane Interface. ACS Cent. Sci. 2018;4(10):1344–1351. doi:10.1021/acscentsci.8b00383
   PubMed Web of Science ®Google Scholar
• Wiraja C, Zhu Y, Lio DCS, et al. Framework nucleic acids as programmable carrier for transdermal drug delivery. Nat Commun. 2019;10(1):1147. doi:10.1038/s41467-019-09029-9
   PubMedGoogle Scholar
• Liu Y, Sun Y, Li S, et al. Tetrahedral Framework Nucleic Acids Deliver Antimicrobial Peptides with Improved Effects and Less Susceptibility to Bacterial Degradation. Nano Lett. 2020;20(5):3602–3610. doi:10.1021/acs.nanolett.0c00529
   PubMed Web of Science ®Google Scholar
• Xiao D, Li Y, Tian T, et al. Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma. ACS Appl Mater Interfaces. 2021;13(5):6109–6118. doi:10.1021/acsami.0c23005
   PubMed Web of Science ®Google Scholar
• Xi L, Lin Z, Qiu F, et al. Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment. Acta Pharmaceutica Sinica B. 2022;12(1):339–352. doi:10.1016/j.apsb.2021.07.019
   PubMed Web of Science ®Google Scholar
• Sun L, Liu Z, Wang L, et al. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. J Control Release. 2017;254:44–54. doi:10.1016/j.jconrel.2017.03.385
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang F, Du Y, et al. Effect of tetrahedral DNA nanostructures on LPS‐induced neuroinflammation in mice. Chin. Chem. Lett. 2022;33(4):1901–1906. doi:10.1016/j.cclet.2021.10.029
   Web of Science ®Google Scholar
• Zhang Q, Lin S, Shi S, et al. Anti-inflammatory and Antioxidative Effects of Tetrahedral DNA Nanostructures via the Modulation of Macrophage Responses. ACS Appl Mater Interfaces. 2018;10(4):3421–3430. doi:10.1021/acsami.7b17928
   PubMed Web of Science ®Google Scholar
• Guo Z, Gu Y, Wang C, et al. Enforced expression of miR-125b attenuates LPS-induced acute lung injury. Immunol Lett. 2014;162(1, Part A):18–26. doi:10.1016/j.imlet.2014.06.008
   PubMed Web of Science ®Google Scholar
• Chen X-M, Gao K-X, Wu X-D, et al. Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Attenuates Rheumatoid Arthritis through Upregulating miR-125b to Suppress NF-κB-Induced Inflammation by Targeting CK2. J Immunol Res. 2022;2022:2836128. doi:10.1155/2022/2836128
   PubMed Web of Science ®Google Scholar
• Qiu F, Xi L, Chen S, Zhao Y, Wang Z, Zheng Y. Celastrol Niosome Hydrogel Has Anti-Inflammatory Effect on Skin Keratinocytes and Circulation without Systemic Drug Exposure in Psoriasis Mice. Int j Nanomed. 2021;16:6171–6182. doi:10.2147/IJN.S323208
   PubMed Web of Science ®Google Scholar
• Jörgensen AM, Wibel R, Bernkop-Schnürch A. Biodegradable Cationic and Ionizable Cationic Lipids: a Roadmap for Safer Pharmaceutical Excipients. Small. 2023;19(17):2206968. doi:10.1002/smll.202206968
   PubMed Web of Science ®Google Scholar
• Zhang H, Han X, Alameh M-G, et al. Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery. J Biomed Mater Res Part A. 2022;110(5):1101–1108. doi:10.1002/jbm.a.37356
   PubMed Web of Science ®Google Scholar
• Parhiz H, Brenner JS, Patel PN, et al. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). J Control Release. 2022;344:50–61. doi:10.1016/j.jconrel.2021.12.027
   PubMed Web of Science ®Google Scholar